A Cannabis plant is pictured at the "Weed the People" event as enthusiasts gather to celebrate the legalization of the recreational use of marijuana in Portland, OregonReuters
Welcome to Insider Cannabis, our weekly newsletter where we're bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar global cannabis boom.
History made: The House voted to federally decriminalize marijuana and expunge records of those convicted under previous laws by a margin of 228 to 164. It's the first time that a chamber of Congress has passed decriminalization, even if the bill's chances in the Senate are slim.
Also, of note, cannabis consumers spent approximately $238 million on marijuana over Thanksgiving weekend, according to data compiled by cannabis tech company Akerna. The sales on what the cannabis industry calls Green Wednesday - the Wednesday ahead of Thanksgiving - were 80% above the daily average for the year.
US lawmakers just voted for the first time to federally decriminalize cannabis.
The bill, called the Marijuana Opportunity Reinvestment and Expungement Act, or the "MORE Act, would end criminal penalties for anyone who sells cannabis in states where that's legal, decriminalize the use of cannabis throughout the US, and formally allow states to chart their own course in establishing commercial marijuana sales.
Figuring out how to invest in cannabis can be complicated, though there are a few ways retail investors can get in on the green rush. David Bonnier, founding partner at cannabis investment firm Enexis, and Mitch Baruchowitz, managing partner at Merida Capital Partners, offered their insight into what investors should consider when looking at the industry.
Advertisement
In short, both investors say that though tools like exchange-traded funds (ETFs), which offer diversified portfolios of stocks, are a good option "if you don't want to do much work," doing research into the companies and markets themselves are the keys to successfully investing in the nuanced space.
Oregon made history in November when it passed a measure to create a regulated therapeutic psilocybin program, opening the door to what could be the first legal market for psychedelic medications on the state level.
But psychedelics giants like ATAI, MindMed, and others say they're unlikely to dive into the state, citing the unknowns surrounding the program as well as the risk associated with entering a market that's still illegal on the federal level.
Cannabis is expected to become a $100 billion industry by 2030, according to analysts from Cowen. The analysts projected growth in legal sales and illicit sales to give a picture of what the total market could look like in the US by 2030 if marijuana is federally legalized.
Hydroponics company Hydrofarm is preparing to go public on the Nasdaq Global Market. JP Morgan and Stifel are acting as bookrunners on the offering.
Sanity Group, a German cannabis startup, has raised $4.8 million from a group of investors including Will.i.am and Alyssa Milano. The new funding brings the startup's total amount raised to $29 million.
Ackrell SPAC Partners filed with the SEC on Tuesday to raise $100 million to go after deals in the hemp and CBD space. The SPAC will list on the NASDAQ under the ticker ACKIU.
Organigram reported $20.4 million in revenue and a net loss of $38.6 million for the three months that ended August 31.
Policy moves
The United Nations on Wednesday voted to reschedule cannabis and acknowledge that the plant has therapeutic value and is not "liable to produce ill-effects."
The NBA said it will not test players for marijuana use this upcoming season, building off of the league's decision to not test players entering the NBA bubble in Orlando to finish the previous season. Marijuana is still on the NBA's banned substances list.
Science and research
New York University's Public Safety Lab compiled statistics on cannabis and incarceration in the US by county as part of its Jail Data Initiative.
Research conducted at the University of Western Ontario and published in the Journal of Neuroscience found that a molecule in green tea can mitigate the harm of chronic adolescent cannabis use.
Cannabis debt raises are rising across the US, according to data from Viridian Capital Advisors. Between 2019 and 2020, debt raises among cannabis companies have almost doubled - from $563 million to $940 million. They've also moved East - as has M&A activity. This year, the three states of Illinois, Massachusetts and New York made up 93% of debt issuance, much of which came from larger players like Curaleaf, LeafLink, and Cresco.
NewsletterSIMPLY PUT - where we join the dots to inform and inspire you. Sign up for a weekly brief collating many news items into one untangled thought delivered straight to your mailbox.
A New York City gang accused of killing a 15-year-old boy also created a fake nonprofit to solicit donations and fund their lifestyles, prosecutors say
A veteran CIA officer was killed after his mission to capture a suspected bomb-maker called 'Engineer Ismail' was ambushed by Islamic militants
Billionaire investor Bill Ackman says the US should give every American cash at birth so they can retire a millionaire